Shire plc: First 2006 Product Launched, Another Approved and Pipeline Progression on Track (FinanzNachrichten)
BASINGSTOKE, England and PHILADELPHIA, Pennsylvania, July 28 /PRNewswire-FirstCall/ -- Shire plc announces results for the second quarter 2006 and confirms good progression in drugs pipeline.

Cepheid's Xpert GBS(TM) Test For Group B Streptococcus Run On The GeneXpert(R) System Receives 510(k) Clearance From FDA (Medical News Today)
Cepheid (Nasdaq:CPHD), a broad-based molecular diagnostics company, today announced the510(k) clearance of its first clinical molecular diagnostic product for theUnites States market. Cepheid received 510(k) clearance from the U.S. Food& Drug Administration (FDA) to market its Xpert GBS(TM) test for Group BStreptococcus (GBS) on its GeneXpert(R) platform. [click link for full article]